CD47 antibodies and methods of use thereof
US9663575B2 · kind B2 · utility
19Cited by
69References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2015 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Apr 29, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/21
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates generally to monoclonal antibodies that recognize CD47, more specifically to CD47 antibodies that do not cause a significant level of agglutination of cells, to methods of generating these antibodies, and to methods of using these monoclonal antibodies as therapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.